Vanberra Signal
Free trial

EPITOPIC

Curated by Signal

Provider of cell therapy and antibody services

Health Technologyepitopic.com

Overview

Provider of cell therapy and antibody services. The company's technology combines premium trinucleotide DNA libraries, peptide phage display, next-generation sequencing, and a new way of data analysis for offering services in antibody fingerprinting and epitope mapping. The company provides the precise identification of binding sites and the modifications accepted for antibody binding. The company was formed after 4 years of collaboration between PolyQuant GmbH in Bad Abbach and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig, Germany.

Key facts

Founded
2016
Headquarters
Leipzig, Germany
Stage
Sign up to view
Industry
Health Technology

Contact

Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Schallquelle

    Provider of application offering training for people with cochlear implantation

    Health TechnologyUlm, Germany

  • ELM

    Provider of computational tool for protein sequence analysis

    Health TechnologyHeidelberg, Germany

  • Onelife Health

    Provider of holistic health solutions for expectant parents and healthcare professionals

    Health TechnologyHamburg, Germany

About EPITOPIC

What does EPITOPIC do?

Provider of cell therapy and antibody services.

Where is EPITOPIC headquartered?

EPITOPIC is headquartered in Leipzig, Germany.

When was EPITOPIC founded?

EPITOPIC was founded in 2016.

Which sector is EPITOPIC in?

EPITOPIC operates in Health Technology.

Who are EPITOPIC's competitors?

Companies similar to EPITOPIC include Schallquelle, ELM, and Onelife Health.